Autism Spectrum Disorder
1,274
250
315
616
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
130 trials with published results (10%)
Research Maturity
616 completed trials (48% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.2%
41 terminated out of 1274 trials
93.8%
+7.3% vs benchmark
2%
30 trials in Phase 3/4
21%
130 of 616 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 616 completed trials
Clinical Trials (1274)
Patterns of Neurodevelopmental Disorders
Characterization of Social Cognition Profiles in Children and Adolescents With Neurodevelopmental Disorders: a Clinical Study Using a Multidimensional Battery
FMS - CrossFit Training Program(FCTP) to Improve School Readiness in Preschool Children With Autism Spectrum Disorder
Genome Environment Microbiome and Metabolome in Autism Study
The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavioral Changes in Children With Autism Spectrum Disorder
Comparison of Efficacy and Safety of Vita 6 Versus Zinc Along With Applied Behavioural Therapy
TB006 for Autism Spectrum Disorder
A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Children With Developmental Delays
Implementing Action-Based Cognitive Remediation for Transdiagnostic Cognitive Difficulties in a Tertiary Mental Health Hospital
Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole
Developing Brain, Impulsivity and Compulsivity
Culturally Adapted Intervention to Prevent Self-harm in Young People With Autism
Mobile Health Intervention for Children With Autism
Comparing Two Different Emotion Therapies for Autistic Youth and Young Adults
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.
Intranasal Insulin for Autism Spectrum Disorder in Children and Young Adults Aged 4 to 21 Years
Improving Barriers to Care Access for Children With Autism and Related Needs Via Telehealth for Evaluation, Care Navigating, and Caregiver Coaching
Probiotic Therapy for Children and Adults With Autism Spectrum Disorder
Addressing Disparities in Autism Spectrum Disorder Diagnosis Using a Direct-to-home Telemedicine Tool